ABIVAX Company Profile

News Articles [27 Associated News Articles listed on BioPortfolio]

Abivax believes it has made progress towards HIV cure

Abivax has unveiled new data that may suggest its clinical candidate ABX464 could be a safe, functional cure for human...Read More... The post Abivax believes it has made progress towards HIV cure app...

Abivax completes dosing in ABX464-101 trial for UC

Abivax has completed dosing patients in the ABX464-101 trial, a Phase lla clinical trial investigating the safety and efficacy of...Read More... The post Abivax completes dosing in ABX464-101 trial fo...

Draining HIV Viral Reservoirs: Abivax Prepares ABX464 Cure For Phase IIb

Abivax CEO outlines next moves after Phase IIa trial using ABX464 showed first proof in human of viral load reduction...    

Abivax reports positive topline results from ABX464-101 trial for UC

Abivax has reported positive topline results from its Phase lla ABX464-101 clinical trial evaluating the safety and efficacy of ABX464...Read More... The post Abivax reports positive topline results f...

CEO Interview: Ulcerative Colitis Trial Shows Abivax's HIV Candidate Has Broader Potential

Abivax Phase IIa data for its lead asset showed impressive results in ulcerative colitis. The biotech's CEO tells Scrip trials...   

DGAP-News: ABIVAX schließt Patientenrekrutierung für klinische Phase-2a-Studie mit ABX464 zur Behandlung von Patienten mit Colitis ulcerosa ab (deutsch)

ABIVAX schließt Patientenrekrutierung für klinische Phase-2a-Studie mit ABX464 zur Behandlung von Patienten mit Colitis ulcerosa ab DGAP-News: ABIVAX / Schlagwort(e): Studie ABIVAX schließt Patien....

DGAP-News: ABIVAX ernennt Ian McGowan zum Vorsitzenden und Jürgen Rockstroh zum neuen Mitglied seines wissenschaftlichen Beirats (deutsch)

ABIVAX ernennt Ian McGowan zum Vorsitzenden und Jürgen Rockstroh zum neuen Mitglied seines wissenschaftlichen Beirats DGAP-News: ABIVAX / Schlagwort(e): Personalie ABIVAX ernennt Ian McGowan zum V...

Abivax sets its course on colitis and Crohn’s

French biotech moves on with the late stage drug development, after publishing impressive clinical trial results of ABX464 for treatment of colitis and hinting its potential in Crohn’s disease. Ab...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

ABIVAX